| Structure | Chemical Name | CAS | MF |
|
2-Methoxy-4-fluorobenzyl chloride
|
157068-04-7
|
C8H8ClFO
|
|
4-(4H-1,2,4-TRIAZOL-4-YL)BENZOIC ACID
|
157069-48-2
|
C9H7N3O2
|
|
4-AMINO-3-CHLORO-5-METHYLBENZOIC ACID
|
157069-52-8
|
C8H8ClNO2
|
|
2-Furancarboxamide,3-hydroxy-N,5-dimethyl-(9CI)
|
157070-43-4
|
C7H9NO3
|
|
1H-Pyrrole-1-aceticacid,1-methylethylester(9CI)
|
157071-49-3
|
C9H13NO2
|
|
3-chloro-N,N-diMethyl-5-(trifluoroMethyl)pyridin-2-aMine
|
157071-79-9
|
C8H8ClF3N2
|
|
4-Chloro Trazodone
|
157072-19-0
|
C19H22ClN5O
|
|
spiroquinazoline
|
157075-58-6
|
C23H19N5O3
|
|
Pentalene, octahydro-1-(1-methylethyl)-, (1alpha,3aba,6aba)- (9CI)
|
157078-22-3
|
C11H20
|
|
Pentalene, octahydro-1-(1-methylethyl)-, (1alpha,3aalpha,6aalpha)- (9CI)
|
157078-23-4
|
C11H20
|
|
Pentalene, octahydro-2-(1-methylethyl)-, (2alpha,3aba,6aba)- (9CI)
|
157078-24-5
|
C11H20
|
|
isohomohalichondrin B
|
157078-48-3
|
C61H86O19
|
|
imidapril
|
157085-07-9
|
C20H27N3O6
|
|
LIPEDOSIDEB-III
|
157085-48-8
|
C31H44O12
|
|
Dimorphecolic acid methyl
|
157085-57-9
|
C19H34O3
|
|
2-Pyrrolidinemethanol,4-hydroxy-1-methyl-,trans-(9CI)
|
157087-65-5
|
C6H13NO2
|
|
Pyridinium, 1-(carboxymethyl)-, ar-Me derivs., inner salts
|
157089-27-5
|
|
|
|
pherofunginum
|
157090-78-3
|
|
|
|
CR5 protein
|
157091-96-8
|
|
|
2-PROPENAL, 3-(4-(ACETYLOXY)PHENYL)-,(2E)
|
157096-53-2
|
C11H10O3
|
|
RLH 033
|
157097-10-4
|
C25H31ClN2O4
|
|
4-(3,4,5-TRIMETHOXYPHENOXY)PIPERIDINE HYDROCHLORIDE
|
157098-36-7
|
C14H21NO4
|
|
1H-Tetrazole-5-carboxylicacid,2-methylpropylester(9CI)
|
157101-43-4
|
C6H10N4O2
|
|
7-HYDROXY-4-METHOXYMETHYLCOUMARIN
|
157101-77-4
|
C11H10O4
|
|
2-Iodonaphthalene-1-sulfonic acid
|
157103-41-8
|
C10H7IO3S
|
|
Noopept
|
157115-85-0
|
C17H22N2O4
|
|
5'-phosphopyridoxyl-7-azatryptophan
|
157117-38-9
|
C18H21N4O7P
|
|
Benzeneacetyl chloride, 4-(dimethylamino)-alpha-oxo- (9CI)
|
157119-18-1
|
C10H10ClNO2
|
|
4-methyl-5-oxo-2,5-dihydrofuran-3-yl trifluoromethanesulfonate
|
157123-02-9
|
C6H5F3O5S
|
|
3-(5-METHYL-1H-TETRAZOL-1-YL)PHENOL
|
157124-40-8
|
C8H8N4O
|
|
4-(5-METHYL-1H-TETRAZOL-1-YL)PHENOL
|
157124-41-9
|
C8H8N4O
|
|
1-phosphono-4-(3-phenoxyphenyl) butylsulfonic acid tripotassiuM salt
|
157124-84-0
|
C16H16K3O7PS
|
|
BMS 188745 Potassium Salt
|
157126-15-3
|
C16H16K3O7PS
|
|
1-(3-iodopropyl)-3-phenoxybenzene
|
157126-72-2
|
C15H15IO
|
|
1-(hydroxymethyl)-5-pyridin-3-yl-pyrrolidin-2-one
|
157129-55-0
|
C10H12N2O2
|
|
1-Naphthalenecarboxylicacid,2-amino-1,2-dihydro-1-methyl-,(1R-cis)-(9CI)
|
157131-00-5
|
C12H13NO2
|
|
(S)-α-Methoxy-2-naphthaleneacetic acid, (S)-2-NMA
|
157134-51-5
|
C13H12O3
|
|
DI-8-ANEPPS
|
157134-53-7
|
C36H52N2O3S
|
|
Ethanone, 1-[4-(chloromethyl)-2,5-dimethyl-3-furanyl]- (9CI)
|
157134-96-8
|
C9H11ClO2
|
|
N-((tert-butoxycarbonyl)alanyl-prolyl-phenylalanyl)-O-benzoylhydroxylamine
|
157135-53-0
|
C29H36N4O7
|
|
Oxiranecarboxylic acid, 3-methyl-2-(1-methylethyl)-, ethyl ester (9CI)
|
157136-56-6
|
C9H16O3
|
|
(2S,3S,4S)-2-METHYL-2-(CARBOXYCYCLOPROPYL)GLYCINE
|
157141-16-7
|
C7H11NO4
|
|
CYANOMETHYLENETRIBUTYLPHOSPHORANE
|
157141-27-0
|
C14H28NP
|
|
N-(5-chloropyridin-2-yl)-2-cyanoacetamide
|
157141-56-5
|
C8H6ClN3O
|
|
2-AMINO-2-(4-METHYLPHENYL)ETHANOL
|
157142-48-8
|
C9H13NO
|
|
1H-Pyrazole-5-carbonyl chloride, 4-chloro-1-methyl- (9CI)
|
157142-50-2
|
C5H4Cl2N2O
|
|
3-Ethoxy-4-methylbenzaldehyde
|
157143-20-9
|
C10H12O2
|
|
harzianic acid
|
157148-06-6
|
C19H27NO6
|
|
13,14-dihydroxyretinol
|
157153-38-3
|
C20H32O3
|
|
|
peroxisomal farnesylated protein
|
157153-79-2
|
|
|
(R)-(1-PHENYL-ETHYL)-PYRIDIN-2-YLMETHYL-AMINE
|
157160-17-3
|
C14H16N2
|
|
METHYL 3-HYDROXY-5-TRIFLUOROMETHYLTHIOPHENE-2-CARBOXYLATE
|
157162-16-8
|
C7H5F3O3S
|
|
Tilidin-phosphat
|
157163-65-0
|
C17H26NO6P
|
|
3,4-DIFLUORO-4'-METHYLBENZOPHENONE
|
157165-29-2
|
C14H10F2O
|
|
Glycine, N-[(hydroxyamino)carbonyl]-, ethyl ester (9CI)
|
157166-51-3
|
C5H10N2O4
|
|
N-Desmethyl Dapoxetine
|
157166-71-7
|
C20H22ClNO
|
|
4,5-DIANILINOPHTHALIMIDE
|
157168-02-0
|
C20H15N3O2
|
|
METHYL [5-METHYL-2-(4-METHYLPHENYL)-1,3-OXAZOL-4-YL]ACETATE
|
157169-68-1
|
C14H15NO3
|
|
2-[5-METHYL-2-(4-METHYLPHENYL)-1,3-OXAZOL-4-YL]ETHANOL
|
157169-71-6
|
C13H15NO2
|
|
2-(5-methyl-2-phenyl-4-oxazolylmethoxy)-5-nitropyridine
|
157169-73-8
|
C16H13N3O4
|
|
Alanine, N-(2-methyl-1-oxopropyl)- (9CI)
|
157170-72-4
|
C7H13NO3
|
|
5-Isoxazoleethanol,3-methoxy-4-methyl-(9CI)
|
157170-95-1
|
C7H11NO3
|
|
D-[1,6-13C2,6,6'-2H2]GLUCOSE
|
157171-80-7
|
C6H10D2O6
|
|
22-Dehydro 25-Hydroxy Cholesterol 3-Acetate
|
157171-88-5
|
C29H46O3
|
|
2-(4-(2-piperidinoethoxy)phenyl)-3-(4-methoxyphenyl)-2H-benzopyran
|
157173-60-9
|
C29H31NO3
|
|
4H-Thieno[3,4-c]pyrrole,5,6-dihydro-1-(1-methylethyl)-(9CI)
|
157176-23-3
|
C9H13NS
|
|
Alatrofloxacin
|
157182-32-6
|
C26H25F3N6O5
|
|
S-2 METHANANDAMIDE
|
157182-48-4
|
C23H39NO2
|
|
R(+)-ARACHIDONYL-1'-HYDROXY-2'-PROPYLAMIDE
|
157182-49-5
|
C23H39NO2
|
|
S-1 METHANANDAMIDE
|
157182-50-8
|
C23H39NO2
|
|
mycestericin D
|
157183-67-0
|
C21H39NO5
|
|
14-epicochlioquinone B
|
157183-69-2
|
C28H40O6
|
|
Cepacidine A
|
157184-36-6
|
C52H85N11O22
|
|
hepatitis C virus envelope 2 protein
|
157184-61-7
|
C196H311N57O57S
|
|
|
atsizol
|
157185-20-1
|
|
|
|
Cepalycin I
|
157185-35-8
|
|
|
|
Cepalycin II
|
157185-36-9
|
|
|
1-Fluoro-4-(pyrrolidinosulfonyl)benzene
|
157187-14-9
|
C10H12FNO2S
|
|
METHYL (2S,4S)-4-PHENOXY-2-PYRROLIDINECARBOXYLATE
|
157187-62-7
|
C12H15NO3
|
|
(E)-4-tert-butyl 1-ethyl 2-(4-fluorobenzylidene)succinate
|
157188-11-9
|
C17H21FO4
|
|
Butanedioic acid, 2-(triphenylphosphoranylidene)-, 4-(1,1-diMethylethyl) 1-ethyl ester
|
157188-20-0
|
C28H31O4P
|
|
6-Benzothiazolol, 5,7-dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-, hydrogen sulfate (ester) (9CI)
|
157192-07-9
|
C16H17N3O4S2
|
|
-bta--D-Glucopyranosiduronic acid, 5,7-dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-6-benzothiazolyl (9CI)
|
157192-08-0
|
C22H25N3O7S
|
|
1,3-Dithiolane,4-methyl-2-(1-methylethyl)-(9CI)
|
157194-57-5
|
C7H14S2
|
|
Pyrazolo[1,5-a]pyridin-5-ol, 4,5,6,7-tetrahydro-2-methyl-
|
157196-09-3
|
C8H12N2O
|
|
3-Butenenitrile, 3-bromo-2-oxo-
|
157196-76-4
|
C4H2BrNO
|
|
1,3-DI-T-BUTYLIMIDAZOL-2-YLIDENE
|
157197-53-0
|
C11H20N2**
|
|
1,3-DI-T-BUTYLIMIDAZOLIUM CHLORIDE
|
157197-54-1
|
C11H21ClN2
|
|
2-(1H-BENZIMIDAZOL-1-YL)PROPANOIC ACID
|
157198-79-3
|
C10H10N2O2
|
|
1H-Benzimidazole-1-acetylchloride(9CI)
|
157198-80-6
|
C9H7ClN2O
|
|
Desmethyl Cerivastatin, Sodium Salt
|
157199-28-5
|
C25H31FNNaO5
|
|
1H-INDOLE-1-CARBOXYLIC ACID,2,3-DIHYDRO-5,6-DIHYDROXY-,PHENYLMETHYL ESTER
|
157199-30-9
|
C16H15NO4
|
|
PO-PRO 1
|
157199-56-9
|
C20H27IN3O+
|
|
BO-PRO 1
|
157199-57-0
|
C20H27I2N3S
|
|
3-METHYL-2-([1-[3-(TRIMETHYLAMMONIO)PROPYL]-4(1H)-QUINOLINYLIDENE]METHYL)-1,3-BENZOTHIAZOL-3-IUM DIIODIDE
|
157199-59-2
|
C24H29I2N3S
|
|
YO-PRO 3
|
157199-62-7
|
C26H31I2N3O
|
|
3-METHYL-2-((E)-3-[1-[3-(TRIMETHYLAMMONIO)PROPYL]-4(1H)-QUINOLINYLIDENE]-1-PROPENYL)-1,3-BENZOTHIAZOL-3-IUM DIIODIDE
|
157199-63-8
|
C26H31I2N3S
|
|
4-(biotin-epsilon-(aminohexanoyl)oxymethyl)-3-nitrobenzoyl-glycyl-(propionyl)ornithinyl-epsilon-aminohexanoyl-cholecystokinin
|
157203-06-0
|
C89H120N18O27S4
|
|
4-alanyloxymethyl-3-nitrobenzoyl-epsilon-aminohexanoyl-cholecystokinin
|
157203-07-1
|
C66H83N13O22S3
|
|
dinitrosoglycolurile
|
157203-19-5
|
C8H8N12O8
|